A new nasal-delivered nanotherapy shows promise against aggressive glioblastoma tumors. By activating the STING immune ...
Evo’s success wasn’t limited to proteins. When they tested a different toxin that had an RNA-based inhibitor, the system ...
Researchers at Washington University School of Medicine in St. Louis, along with collaborators at Northwestern University, ...
News Medical on MSN
Nasal drops fight brain tumors noninvasively
Glioblastoma tumors form from brain cells called astrocytes and are the most common kind of brain cancer, affecting roughly ...
Two complementary studies led by researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS ...
The Brighterside of News on MSN
Gene-edited fungus tastes like meat and cuts protein’s climate impact by more than 50%
The way the world grows protein is straining the planet. Raising animals for food covers close to 40 percent of all farmland, ...
After revoking Sarepta’s award in July and awarding one to Krystal last month, the FDA’s platform technology designation program appears to be back on track. These six biotechs could be on the ...
News-Medical.Net on MSN
Study clarifies how spermine can guard against Alzheimer’s and Parkinson’s
Researchers at the Paul Scherrer Institute PSI have clarified how spermine - a small molecule that regulates many processes ...
Yet it quickly became evident from talks by Simon Yates from AstraZeneca (AZ) and Marius Lutz from Roche, that building a ...
Shanghai Stock Exchange listed company HitGen Inc. ("HitGen", SSE: 688222.SH), today announced that it has entered into a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback